GraniteShares Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $730K | Sell |
9,330
-509
| -5% | -$39.8K | 0.45% | 69 |
|
|
2025
Q1 | $713K | Sell |
9,839
-515
| -5% | -$37.3K | 0.45% | 65 |
|
|
2024
Q4 | $767K | Sell |
10,354
-2,132
| -17% | -$158K | 0.49% | 66 |
|
|
2024
Q3 | $824K | Buy |
12,486
+1,399
| +13% | +$92.3K | 0.56% | 67 |
|
|
2024
Q2 | $1.02M | Buy |
11,087
+1,091
| +11% | +$101K | 0.34% | 60 |
|
|
2024
Q1 | $955K | Sell |
9,996
-597
| -6% | -$57K | 0.51% | 65 |
|
|
2023
Q4 | $808K | Sell |
10,593
-825
| -7% | -$62.9K | 0.73% | 65 |
|
|
2023
Q3 | $791K | Buy |
+11,418
| New | +$791K | 0.74% | 64 |
|
|
2022
Q3 | – | Sell |
-2,358
| Closed | -$224K | – | 139 |
|
|
2022
Q2 | $224K | Sell |
2,358
-494
| -17% | -$46.9K | 0.16% | 132 |
|
|
2022
Q1 | $335K | Sell |
2,852
-93
| -3% | -$10.9K | 0.18% | 126 |
|
|
2021
Q4 | $381K | Buy |
+2,945
| New | +$381K | 0.18% | 127 |
|